Fri, Aug 1, 2014, 9:37 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Aethlon Medical, Inc. Message Board

  • robert.vince robert.vince Dec 3, 2012 6:28 AM Flag

    Aethlon Medical Announces Initiation of Compassionate-Use Program to Treat Hepatitis C Virus (HCV)

    SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, today announced the initiation of a compassionate-use clinical program to treat individuals infected with Hepatitis C virus (HCV). The compassionate-use program, which has been approved by the Institutional Review Board at the Medanta Medicity Institute (Medicity), will provide individuals who previously failed or subsequently relapsed standard-of-care drug regimens with treatment access to the Aethlon Hemopurifier®. The Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dosing, duration and tolerability of drug therapies.

    The Medicity is a $360 million multi-specialty medical institute established to be a premier center for medical tourism in India.

 
AEMD
0.1349-0.0001(-0.07%)Aug 1 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.